menu
    • menu

    Company profile for Alto Neuroscience

    NEW Drugs in Dev: 8
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapid...
    To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. We aim to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alto NeuroscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    369 South San Antonio Road Los Altos, CA 94022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.altoneuroscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/altoneuroscience/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alto Halts Work On PDE4 Inhibitor After Ph. 2 Schizophrenia Fail
    Alto Halts Work On PDE4 Inhibitor After Ph. 2 Schizophrenia Fail

    02 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/alto-halts-work-pde4-inhibitor-after-failed-phase-2-schizophrenia-study

    FIERCE BIOTECH
    02 Apr 2026
    Share Share
    Alto Neuroscience Reports Full Year 2025 Financial Results
    Alto Neuroscience Reports Full Year 2025 Financial Results

    16 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260316041876/en/Alto-Neuroscience-Reports-Full-Year-2025-Financial-Results-and-Recent-Business-Highlights

    BUSSINESSWIRE
    16 Mar 2026
    Share Share
    Alto Neuroscience Announces Participation At The Stifel 2026
    Alto Neuroscience Announces Participation At The Stifel 2026

    13 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260313166897/en/Alto-Neuroscience-Announces-Participation-at-the-Stifel-2026-Virtual-CNS-Forum

    BUSSINESSWIRE
    13 Mar 2026
    Share Share
    Alto Neuroscience To Participate In Investor Conferences
    Alto Neuroscience To Participate In Investor Conferences

    23 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260223767838/en/Alto-Neuroscience-Announces-Participation-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    23 Feb 2026
    Share Share
    Alto Neuroscience Wraps Up Enrollment of ALTO-101 Phase 2 Study
    Alto Neuroscience Wraps Up Enrollment of ALTO-101 Phase 2 Study

    13 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260213343048/en/Alto-Neuroscience-Announces-Completion-of-Enrollment-in-Phase-2-Proof-of-Concept-Study-of-ALTO-101-in-Cognitive-Impairment-Associated-with-Schizophrenia

    BUSINESSWIRE
    13 Feb 2026
    Share Share
    Alto Neuroscience Highlights Neuroplasticity in Psychiatric Care
    Alto Neuroscience Highlights Neuroplasticity in Psychiatric Care

    03 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260203088315/en/Alto-Neuroscience-Highlights-Invited-Review-in-American-Journal-of-Psychiatry-Establishing-Neuroplasticity-as-a-Core-Driver-of-Psychiatric-Disease-and-Treatment

    BUSINESSWIRE
    03 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search